Tuberc Respir Dis.
2014 Dec;77(6):237-242. 10.4046/trd.2014.77.6.237.
Respiratory Review of 2014: Asthma
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. dextro70@gmail.com
- KMID: 1842990
- DOI: http://doi.org/10.4046/trd.2014.77.6.237
Abstract
- Asthma is a chronic inflammatory disease of the airway that comprises a variety of etiologies and inflammatory phenotypes. Clinically, there is a wide range of patients with varying severities and responses to individual drugs. The introduction of inhaled corticosteroid therapy has dramatically changed the treatment of asthma. Recent development of new therapies suggests the possibility of another breakthrough. These can be categorized as follows: anti-cytokine therapies that usually target eosinophilic inflammation, sublingual immunotherapy, and bronchial thermoplasty. In this paper, we will review the major articles related to asthma treatment that were published in 2013.
MeSH Terms
Cited by 2 articles
-
Investigation of the Possible Role of the Hippo/YAP1 Pathway in Asthma and Allergy
Lili E. Fodor, András Gézsi, ldikó Ungvári, Ágnes F. Semsei, Zsófia Gál, Adrienne Nagy, Gabriella Gálffy, Lilla Tamási, András Kiss, Péter Antal, Csaba Szalai
Allergy Asthma Immunol Res. 2017;9(3):247-256. doi: 10.4168/aair.2017.9.3.247.Allergic Rhinitis in Preschool Children and the Clinical Utility of FeNO
Jisun Yoon, Yean Jung Choi, Eun Lee, Hyun-Ju Cho, Song-I Yang, Young-Ho Kim, Young-Ho Jung, Ju-Hee Seo, Ji-won Kwon, Hyo-Bin Kim, So-Yeon Lee, Bong-Seong Kim, Jung Yeon Shim, Eun-Jin Kim, Joo-Shil Lee, Soo-Jong Hong
Allergy Asthma Immunol Res. 2017;9(4):314-321. doi: 10.4168/aair.2017.9.4.314.
Reference
-
1. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013; 368:2455–2466.2. Busse WW, Holgate S, Kerwin E, Chon Y, Feng J, Lin J, et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med. 2013; 188:1294–1302.3. Laviolette M, Gossage DL, Gauvreau G, Leigh R, Olivenstein R, Katial R, et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol. 2013; 132:1086–1096.4. Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA. 2013; 309:1278–1288.5. Sadatsafavi M, Lynd L, Marra C, Bedouch P, Fitzgerald M. Comparative outcomes of leukotriene receptor antagonists and long-acting beta-agonists as add-on therapy in asthmatic patients: a population-based study. J Allergy Clin Immunol. 2013; 132:63–69.6. Wechsler ME, Laviolette M, Rubin AS, Fiterman J, Lapa e, Shah PL, et al. Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol. 2013; 132:1295–1302.7. McKeever T, Harrison TW, Hubbard R, Shaw D. Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study. Chest. 2013; 144:1788–1794.8. Tse SM, Li L, Butler MG, Fung V, Kharbanda EO, Larkin EK, et al. Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use. Am J Respir Crit Care Med. 2013; 188:1076–1082.9. Short PM, Williamson PA, Anderson WJ, Lipworth BJ. Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma. Am J Respir Crit Care Med. 2013; 187:1308–1314.
